AEGiS-UPI: Multiple AIDS drugs urged as gold standard in poor nations United Press InternationalImportant note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.
Click here to return to United Press International main menu
DonateNow
Print this article




Multiple AIDS drugs urged as gold standard in poor nations

United Press International - Wednesday, 12 July 2000
Michael Smith, UPI Science News


DURBAN, South Africa, July 12 (UPI) -- The drug cocktails used in the United States and other developed countries to treat HIV should be the so-called "gold standard" of care in poor nations as well, according to new guidelines released Wednesday by the International AIDS Society (IAS).

But if the best therapy costs too much, the society said at the 13th International AIDS Conference, doctors in developing countries can resort less effective and riskier methods, even though they are now rarely used in the West.

"There is one standard of care, " IAS President Mark Wainberg told reporters. But Wainberg acknowledged that the multi-drug cocktails used in the developed world are beyond the financial reach of most people in poorer countries.

In that case, he said, the guidelines allow physicians to use less-effective two-drug regimes, which are no longer widely used, since the three-drug cocktails started being prescribed in 1995. Those two-drug regimes are thought to be risky, because they could create drug resistance in HIV, the virus that causes AIDS.

They are also less effective than the three- and four-drug cocktails in suppressing the reproduction of HIV, the guidelines say.

The two-drug combinations usually use a class of medications called nucleoside reverse transcriptase inhibitors; the new cocktails drugs from a class called protease inhibitors.

"It's complicated," Wainberg said, "because there's a lot of evidence the double therapy will keep you alive for a while...but there's no assurance people will do as well" as they would on the three-drug cocktails.

Eric van Praag of the World Health Organization, which helped draft the guidelines, said: "There is one standard and there is reality."

The reality is, he said, that even a less-than-perfect drug therapy is better than nothing. But van Praag added that anti-HIV drugs must be accompanied by counseling on side-effects and safe behavior.

As well, he said, there must be consistent medical monitoring to make sure drug resistance does not occur and that so-called "opportunistic infections" -- such as tuberculosis -- are treated before they become serious.

Italian researcher Stefano Vella, the incoming president of the IAS, said the problem is to "minimize the harm of double nucleoside therapy when it is used."

But physician David Wilson, who works with Doctors without Frontiers in Bangkok, said it's wrong to say there's a single "gold standard" of care. Even in the United States, he said, many doctors still prescribe two-drug combinations for patients whose immune system is still strong.

In fact, he said, most Thai AIDS patients are on double therapy and it is "useful."

Nairobi physician Christopher Ouma said the scientific desire to have the best possible result must give way to the "human aspect -- we have patients who are dying for lack of these drugs."

Access to drugs has been a major theme of this conference, the first International AIDS Conference ever held in the developing world. The IAS guidelines, Wainberg said, are an attempt to reconcile the lack of access with the best available treatment.
000712
UP000722


Copyright © 2000 - United Press International. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through United Press International, Permissions Desk, 1510 H St. N.W. Washington DC 2005. Main Phone Switchboard: 202-898-8000 FAX: 202-898-8057 or 202-898-8147 Email: info@upi.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .